Back to Search Start Over

Disorder Genes Regulate the Progression of Ischemic Stroke through the NF- κ B Signaling Pathway.

Authors :
Wei W
Xin W
Tang Y
Chen Z
Heng Y
Pu M
Yang B
Zuo J
Duan J
Source :
BioMed research international [Biomed Res Int] 2021 Oct 27; Vol. 2021, pp. 2464269. Date of Electronic Publication: 2021 Oct 27 (Print Publication: 2021).
Publication Year :
2021

Abstract

Stroke is an acute cerebrovascular disease, including ischemic and hemorrhagic stroke. Stroke is the second leading cause of death after ischemic heart disease, which accounts for 9% of the global death toll. To explore the molecular mechanisms of the effects of the dysregulated factors, in the GEO database, we obtained transcriptome data from 24 h/72 h of mice with ischemic stroke and 24 h/72 h of normal mice. We then performed differential gene analysis, coexpression analysis, enrichment analysis, and regulator prediction bioinformatics analysis to identify the potential genes. We made a comparison between the ischemic stroke 72 h and the ischemic stroke for 24 h, and 5103 differential genes were obtained ( p < 0.05). Four functional barrier modules were obtained by weighted gene coexpression network analysis. The critical genes of each module were ASTL, Zfp472, Fmr1 gene, and Nap1l1. The results of the enrichment analysis showed ncRNA metabolism, microRNAs in cancer, and biosynthesis of amino acids. These three functions and pathways have the most considerable count value. The regulators of the regulatory dysfunction module were predicted by pivotal analysis of TF and noncoding RNA, and critical regulators including NFKB1 (NF- κ B1), NFKBIA, CTNNB1, and SP1 were obtained. Finally, the pivotal target gene found that CTNNB1, NFKB1, NFKBia, and Sp1 are involved in 18, 32, 2, and 60 target genes, respectively. Therefore, we believe that NFKB1 and Sp1 have a potential role in the progression of ischemic stroke. The NFKB signaling pathway promotes inflammatory cytokines and regulates the progression of ischemic stroke.<br />Competing Interests: The authors declare that they have no competing interests.<br /> (Copyright © 2021 Wei Wei et al.)

Details

Language :
English
ISSN :
2314-6141
Volume :
2021
Database :
MEDLINE
Journal :
BioMed research international
Publication Type :
Academic Journal
Accession number :
34746300
Full Text :
https://doi.org/10.1155/2021/2464269